Authorised

Product identification

Medicine name:
Bovilis Bovipast RSP suspensija injekcijām liellopiem
Active substance:
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated
    2511890.00
    tissue culture infective dose 50
    /
    1.00
    unit(s)
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
    199526000.00
    tissue culture infective dose 50
    /
    1.00
    unit(s)
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated
    9000000000.00
    cells
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Not specified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/05/1660
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 4/04/2024
Download
Source URL: https://medicines.health.europa.eu/veterinary/600000097488